The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Matrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Levy, G. G., Nichols, W. C., Lian, E. C., Foroud, T., McClintick, J. N., McGee, B. M., Yang, A. Y., Siemieniak, D. R., Stark, K. R., Gruppo, R., et al. (2001) · Nature · doi:10.1038/35097008 · Cited by 1,749
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K., et al. (2002) · Nature · doi:10.1038/nature00878 · Cited by 1,099
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
The ADAMs family of metalloproteases: multidomain proteins with multiple functions
Seals, D. F., & Courtneidge, S. A. (2003) · Genes & Development · doi:10.1101/gad.1039703 · Cited by 1,059
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
Sahin, U., Weskamp, G., Kelly, K., Zhou, H.-M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., & Blobel, C. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307137 · Cited by 979
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., et al. (2005) · Nature · doi:10.1038/nature03417 · Cited by 915
PORTER, S., CLARK, I. M., KEVORKIAN, L., & EDWARDS, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20040424 · Cited by 779
Hartmann, D. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2615 · Cited by 680
Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F., Proksch, E., de Strooper, B., Hartmann, D., & Saftig, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500918102 · Cited by 673
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
Wolfsberg, T. G., Primakoff, P., Myles, D. G., & White, J. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.2.275 · Cited by 502
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Greenlee, K. J., Werb, Z., & Kheradmand, F. (2007) · Physiological Reviews · doi:10.1152/physrev.00022.2006 · Cited by 474
ADAMs: focus on the protease domain
Black, R. A., & White, J. M. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80042-2 · Cited by 467
The functions of thrombospondin-1 and-2
Lawler, J. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00143-5 · Cited by 440
Vázquez, F., Hastings, G., Ortega, M.-A., Lane, T. F., Oikemus, S., Lombardo, M., & Iruela-Arispe, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23349 · Cited by 426
Processing of the Notch Ligand Delta by the Metalloprotease Kuzbanian
Qi, H., D. Rand, M., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T., & Artavanis-Tsakonas, S. (1999) · Science · doi:10.1126/science.283.5398.91 · Cited by 415
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
Zhou, B.-B. S., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 374
Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and Notch
Blobel, C. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80519-x · Cited by 356
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342
A Novel, Secreted Form of Human ADAM 12 (Meltrin α) Provokes Myogenesis in Vivo
Gilpin, B. J., Loechel, F., Mattei, M.-G., Engvall, E., Albrechtsen, R., & Wewer, U. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.157 · Cited by 315
Horiuchi, K., Le Gall, S., Schulte, M., Yamaguchi, T., Reiss, K., Murphy, G., Toyama, Y., Hartmann, D., Saftig, P., & Blobel, C. P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0014 · Cited by 310
Iruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J., & Roberts, D. D. (1999) · Circulation · doi:10.1161/01.cir.100.13.1423 · Cited by 308
Metalloproteinases and their inhibitors in tumor angiogenesis
Handsley, M. M., & Edwards, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20945 · Cited by 307
TACE is required for the activation of the EGFR by TGF-α in tumors
Borrell-Pagès, M., Rojo, F., Albanell, J., Baselga, J., & Arribas, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg111 · Cited by 274
Cal, S., Obaya, A. J., Llamazares, M., Garabaya, C., Quesada, V., & López-Otı́n, C. (2002) · Gene · doi:10.1016/s0378-1119(01)00861-7 · Cited by 273
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
Luque, A., Carpizo, D. R., & Iruela-Arispe, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212964200 · Cited by 263
Apte, S. S. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.014 · Cited by 261
Targeting TACE-dependent EGFR ligand shedding in breast cancer
Kenny, P. A., & Bissell, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29518 · Cited by 252
Proteolytic Activities of Human ADAMTS-5
Gendron, C., Kashiwagi, M., Lim, N. H., Enghild, J. J., Thøgersen, I. B., Hughes, C., Caterson, B., & Nagase, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701523200 · Cited by 251
Iba, K., Albrechtsen, R., Gilpin, B., Fröhlich, C., Loechel, F., Zolkiewska, A., Ishiguro, K., Kojima, T., Liu, W., Langford, J. K., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.5.1143 · Cited by 248
Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma
Porter, S., Scott, S. D., Sassoon, E. M., Williams, M. R., Jones, J. L., Girling, A. C., Ball, R. Y., & Edwards, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0398-3 · Cited by 246
ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage
Roy, R., Wewer, U. M., Zurakowski, D., Pories, S. E., & Moses, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409565200 · Cited by 244
Matrix metalloproteinases at cancer tumor–host interface
NOEL, A., JOST, M., & MAQUOI, E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.05.011 · Cited by 239
Self-citationYuan, R., Primakoff, P., & Myles, D. G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.105 · Cited by 234
HB-EGF Is a Potent Inducer of Tumor Growth and Angiogenesis
Ongusaha, P. P., Kwak, J. C., Zwible, A. J., Macip, S., Higashiyama, S., Taniguchi, N., Fang, L., & Lee, S. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0925 · Cited by 219
Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer
Overall, C. M., & Dean, R. A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7890-0 · Cited by 218
Zhang, X.-P., Kamata, T., Yokoyama, K., Puzon-McLaughlin, W., & Takada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7345 · Cited by 211
Koshy, P. J. T., Lundy, C. J., Rowan, A. D., Porter, S., Edwards, D. R., Hogan, A., Clark, I. M., & Cawston, T. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10212 · Cited by 206
Le Pabic, H., Bonnier, D., Wewer, U. M., Coutand, A., Musso, O., Baffet, G., Clément, B., & Théret, N. (2003) · Hepatology · doi:10.1053/jhep.2003.50205 · Cited by 204
Cysteine-Rich Domain of Human ADAM 12 (Meltrin α) Supports Tumor Cell Adhesion
Iba, K., Albrechtsen, R., Gilpin, B. J., Loechel, F., & Wewer, U. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65403-x · Cited by 204
Théret, N., Musso, O., Turlin, B., Lotrian, D., Bioulac-Sage, P., Campion, J.-P., Boudjéma, K., & Clément, B. (2001) · Hepatology · doi:10.1053/jhep.2001.25758 · Cited by 203
Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C‐shaped scaffold
Takeda, S., Igarashi, T., Mori, H., & Araki, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601131 · Cited by 202 · cited 1×
“In a recent study by Takeda et al, the disintegrin domain has been shown not to be available for protein binding due to protein folding [17].”
Taylor, K. L., Henderson, A. M., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2443 · Cited by 199
Little, C. B., Meeker, C. T., Golub, S. B., Lawlor, K. E., Farmer, P. J., Smith, S. M., & Fosang, A. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30765 · Cited by 199
Brynskov, J., Foegh, P., Pedersen, G., Ellervik, C., Kirkegaard, T., Bingham, A., & Saermark, T. (2002) · Gut · doi:10.1136/gut.51.1.37 · Cited by 198
Making the cut: Protease-mediated regulation of angiogenesis
ROY, R., ZHANG, B., & MOSES, M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.022 · Cited by 193
A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions
Mazzocca, A., Coppari, R., De Franco, R., Cho, J.-Y., Libermann, T. A., Pinzani, M., & Toker, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4449 · Cited by 191
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors
Sanderson, M. P., Dempsey, P. J., & Dunbar, A. J. (2006) · Growth Factors · doi:10.1080/08977190600634373 · Cited by 190
Potential Role for ADAM15 in Pathological Neovascularization in Mice
Horiuchi, K., Weskamp, G., Lum, L., Hammes, H.-P., Cai, H., Brodie, T. A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K. T., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5614-5624.2003 · Cited by 189
Human ADAM 12 (Meltrin α) Is an Active Metalloprotease
Loechel, F., Gilpin, B. J., Engvall, E., Albrechtsen, R., & Wewer, U. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16993 · Cited by 187
TACE and other ADAM proteases as targets for drug discovery
Moss, M. L., White, J. M., Lambert, M. H., & Andrews, R. C. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01738-x · Cited by 176
Lemjabbar, H., Li, D., Gallup, M., Sidhu, S., Drori, E., & Basbaum, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207018200 · Cited by 174
Characterization of METH-1/ADAMTS1 Processing Reveals Two Distinct Active Forms
Rodríguez-Manzaneque, J. C., Milchanowski, A. B., Dufour, E. K., Leduc, R., & Iruela‐Arispe, M. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002599200 · Cited by 170
Zhang, Q. H., Thomas, S. M., Lui, V. W. Y., Xi, S., Siegfried, J. M., Fan, H., Smithgall, T. E., Mills, G. B., & Grandis, J. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509719103 · Cited by 168
Schäfer, B., Marg, B., Gschwind, A., & Ullrich, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400129200 · Cited by 168
Liu, Y.-J., Xu, Y., & Yu, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209287 · Cited by 167
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
Amour, A., Knight, C. G., English, W., Webster, A., Slocombe, P. M., Knäuper, V., Docherty, A., Becherer, J. D., Blobel, C., & Murphy, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03047-8 · Cited by 165
Functional Classification of ADAMs Based on a Conserved Motif for Binding to Integrin α9β1
Eto, K., Huet, C., Tarui, T., Kupriyanov, S., Liu, H.-Z., Puzon-McLaughlin, W., Zhang, X.-P., Sheppard, D., Engvall, E., & Takada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200086200 · Cited by 165
Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J.-M., & Noel, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207859 · Cited by 164
Self-citationStone, A. L., Kröger, M., & Sang, Q. A. (1999) · Journal of Protein Chemistry · doi:10.1023/a:1020692710029 · Cited by 161
The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer
Carl‐McGrath, S., Lendeckel, U., Ebert, M. P., Roessner, A., & Röcken, C. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.17 · Cited by 157
Fridman, J. S., Caulder, E., Hansbury, M., Liu, X., Yang, G., Wang, Q., Lo, Y. Y. C., Zhou, B. S., Pan, M., Thomas, S. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2116 · Cited by 157
Kodama, T., Ikeda, E., Okada, A., Ohtsuka, T., Shimoda, M., Shiomi, T., Yoshida, K., Nakada, M., Ohuchi, E., & Okada, Y. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63429-3 · Cited by 156
Blanchot‐Jossic, F., Jarry, A., Masson, D., Bach‐Ngohou, K., PAINEAU, J., Denis, M. G., LABOISSE, C. L., & Mosnier, J. (2005) · The Journal of Pathology · doi:10.1002/path.1814 · Cited by 153
A Role for ADAM12 in Breast Tumor Progression and Stromal Cell Apoptosis
Kveiborg, M., Fröhlich, C., Albrechtsen, R., Tischler, V., Dietrich, N., Holck, P., Kronqvist, P., Rank, F. E., Mercurio, A. M., & Wewer, U. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0262 · Cited by 153
ADAM8 as a Novel Serological and Histochemical Marker for Lung Cancer
Ishikawa, N., Daigo, Y., Yasui, W., Inai, K., Nishimura, H., Tsuchiya, E., Kohno, N., & Nakamura, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1436 · Cited by 149
Wildeboer, D., Naus, S., Sang, Q. A., Bartsch, J. W., & Pagenstecher, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229240.51490.d3 · Cited by 148
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
Foley, S. C., Mogas, A. K., Olivenstein, R., Fiset, P., Chakir, J., Bourbeau, J., Ernst, P., Lemière, C., Martin, J. G., & Hamid, Q. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.665 · Cited by 148
Held‐Feindt, J., Paredes, E. B., Blömer, U., Seidenbecher, C. I., Stark, A. M., Mehdorn, H. M., & Mentlein, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21258 · Cited by 144
Expression of ADAM‐9 mRNA and protein in human breast cancer
O'Shea, C., McKie, N., Buggy, Y., Duggan, C. R., Hill, A. D. K., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11161 · Cited by 143
Ectodomain shedding of the EGF‐receptor ligand epigen is mediated by ADAM17
Şahin, U., & Blobel, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.074 · Cited by 142
ADAM-17 Expression in Breast Cancer Correlates with Variables of Tumor Progression
McGowan, P. M., Ryan, B. M., Hill, A. D. K., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2092 · Cited by 142
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
Murillo, M. M., del Castillo, G., Sánchez, A., Fernández, M., & Fabregat, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208664 · Cited by 140
Huovila, A.-P. J., Almeida, E. A. C., & White, J. M. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80111-6 · Cited by 140
Overexpression of ADAM9 in Non-Small Cell Lung Cancer Correlates with Brain Metastasis
Shintani, Y., Higashiyama, S., Ohta, M., Hirabayashi, H., Yamamoto, S., Yoshimasu, T., Matsuda, H., & Matsuura∥, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3235 · Cited by 139
Lind, G. E., Sahlberg, K. K., Meling, G. I., Teixeira, M. R., Thiis‐Evensen, E., Rognum, T. O., & Lothe, R. A. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/949506 · Cited by 138
Howard, L., Maciewicz, R. A., & Blobel, C. (2000) · Biochemical Journal · doi:10.1042/bj3480021 · Cited by 136
Reiß, K., Ludwig, A., & Säftig, P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.009 · Cited by 136
Molecular Profiling of ADAM12 in Human Bladder Cancer
Fröhlich, C., Albrechtsen, R., Dyrskjøt, L., Rudkjær, L. C. B., Orntoft, T. F., & Wewer, U. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1066 · Cited by 135
Mitsui, Y., Mochizuki, S., Kodama, T., Shimoda, M., Ohtsuka, T., Shiomi, T., Chijiiwa, M., Ikeda, T., Kitajima, M., & Okada, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0377 · Cited by 133
ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y., & Okada, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.022 · Cited by 129
A secreted form of human ADAM9 has an α-secretase activity for APP
Hotoda, N., Koike, H., Sasagawa, N., & Ishiura, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00302-9 · Cited by 127
Ito, K., Okamoto, I., Araki, N., Kawano, Y., Nakao, M., Fujiyama, S., Tomita, K., Mimori, T., & Saya, H. (1999) · Oncogene · doi:10.1038/sj.onc.1203191 · Cited by 126
Membrane associated proteases and their inhibitors in tumour angiogenesis
Noël, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., Maquoi, E., Cataldo, D. D., & Foidart, J. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014472 · Cited by 126
Self-citationAtfi, A., Dumont, E., Colland, F., Bonnier, D., L’Helgoualc’h, A., Prunier, C., Ferrand, N., Clément, B., Wewer, U. M., & Théret, N. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612046 · Cited by 124
Dunn, J. R., Reed, J. E., du Plessis, D. G., Shaw, E. J., Reeves, P., Gee, A. L., Warnke, P. C., & Walker, C. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603006 · Cited by 122
ADAM15 Disintegrin Is Associated with Aggressive Prostate and Breast Cancer Disease
Kuefer, R., Day, K. C., Kleer, C. G., Sabel, M. S., Hofert, M. D., Varambally, S., Zorn, C. S., Chinnaiyan, A. M., Rubin, M. A., & Day, M. L. (2006) · Neoplasia · doi:10.1593/neo.05682 · Cited by 120
Proteolytic cleavage of versican during cardiac cushion morphogenesis
Kern, C. B., Twal, W. O., Mjaatvedt, C. H., Fairey, S. E., Toole, B. P., Iruela‐Arispe, M. L., & Argraves, W. S. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20838 · Cited by 119
Expression of a disintegrin‐like protein in cultured human vascular cells and in vivo
Herren, B., Raines, E. W., & Ross, R. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039960 · Cited by 116
The ADAMs family: Coordinators of nervous system development, plasticity and repair
Yang, P., Baker, K. A., & Hagg, T. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.05.001 · Cited by 116
Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells
Sung, S., Kubo, H., Shigemura, K., Arnold, R. S., Logani, S., Wang, R., Konaka, H., Nakagawa, M., Mousses, S., Amin, M. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4375 · Cited by 115
Expression of METH-1 and METH-2 in pancreatic cancer
Masui, T., Tuji, S., IDA, J., Nakajima, S., KAWAGUCHI, M., Koizumi, M., TOYODA, E., TULACHAN, S., Yasuda, S., HOSOTANI, R., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81290-7 · Cited by 113
Cross, N. A., Chandrasekharan, S., Jokonya, N., Fowles, A., Hamdy, F. C., Buttle, D. J., & Eaton, C. L. (2004) · The Prostate · doi:10.1002/pros.20182 · Cited by 113
Expression and Regulation of a Disintegrin and Metalloproteinase (ADAM) 8 in Experimental Asthma
King, N. E., Zimmermann, N., Pope, S. M., Fulkerson, P. C., Nikolaidis, N. M., Mishra, A., Witte, D. P., & Rothenberg, M. E. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0026oc · Cited by 107
Inhibition of ADAM17 reduces hypoxia‐induced brain tumor cell invasiveness
Zheng, X., Jiang, F., Katakowski, M., Kalkanis, S. N., Hong, X., Zhang, X., Zhang, Z. G., Yang, H., & Chopp, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00440.x · Cited by 106
ADAM 12 Protease Induces Adipogenesis in Transgenic Mice
Kawaguchi, N., Xu, X., Tajima, R., Kronqvist, P., Sundberg, C., Loechel, F., Albrechtsen, R., & Wewer, U. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61136-4 · Cited by 105
Trochon-Joseph, V., Martel-Renoir, D., Mir, L. M., Thomaïdis, A., Opolon, P., Connault, E., Li, H., Grenet, C., Fauvel-Lafève, F., Soria, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3272 · Cited by 100
Yoshimura, T., Tomita, T., Dixon, M. F., Axon, A. T. R., Robinson, P. A., & Crabtree, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/338191 · Cited by 97
Kaushal, G. P., & Shah, S. V. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10078 · Cited by 95
Nagase, H., & Brew, K. (2003) · Biochemical Society Symposia · doi:10.1042/bss0700201 · Cited by 94
McCulloch, D. R., Akl, P., Samaratunga, H., Herington, A. C., & Odorico, D. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0846-3 · Cited by 94
Rocks, N., Paulissen, G., Calvo, F. Q., Polette, M., Gueders, M. M., Munaut, C., Foidart, J., Noël, A., Birembaut, P. L., & Cataldo, D. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602990 · Cited by 93
Self-citationADAMTS: A novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats
Tang, B. L., & Hong, W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00119-2 · Cited by 92
Sagane, K., Ohya, Y., HASEGAWA, Y., & Tanaka, I. (1998) · Biochemical Journal · doi:10.1042/bj3340093 · Cited by 91
Ohtsuka, T., Shiomi, T., Shimoda, M., Kodama, T., Amour, A., Murphy, G., Ohuchi, E., Kobayashi, K., & Okada, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21324 · Cited by 90
McCulloch, D. R., Harvey, M. B., & Herington, A. C. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00305-1 · Cited by 90
The Genetics of Asthma: ADAM33 as an Example of a Susceptibility Gene
Holgate, S. T., Yang, Y., Haitchi, H. M., Powell, R. M., Holloway, J. W., Yoshisue, H., Pang, Y. Y., Cakebread, J. A., & Davies, D. E. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-026aw · Cited by 90
Wild‐Bode, C., Fellerer, K., Kugler, J., Haass, C., & Capell, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601542200 · Cited by 87
Kuno, K., Bannai, K., Hakozaki, M., Matsushima, K., & Hirose, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.105 · Cited by 85
Sieuwerts, A. M., Gelder, M. E. M., Timmermans, M. A. M., Trapman-Jansen, A., Garcia, R. R., Arnold, M., Goedheer, A. J. W., Portengen, H., Klijn, J. G. M., & Foekens, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0560 · Cited by 84
Loss of PTEN is associated with progression to androgen independence
Bertram, J., Peacock, J. W., Fazli, L., Mui, A., Chung, S. W., Cox, M., Monia, B. P., Gleave, M. E., & Ong, C. J. (2006) · The Prostate · doi:10.1002/pros.20411 · Cited by 81
Ringel, J., Jesnowski, R., Moniaux, N., Lüttges, J., Ringel, J., Choudhury, A., Batra, S. K., Klöppel, G., & Löhr, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3287 · Cited by 75
Wayne, G. J., Deng, S.-J., Amour, A., Borman, S., Matico, R., Carter, H. L., & Murphy, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610721200 · Cited by 75
Earlier Onset of Tumoral Angiogenesis in Matrix Metalloproteinase-19–Deficient Mice
Jost, M., Folgueras, A. R., Frérart, F., Pendás, A. M., Blacher, S., Houard, X., Berndt, S., Munaut, C., Cataldo, D. D., Álvarez, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4315 · Cited by 72
Self-citationManso, A. M., Elsherif, L., Kang, S., & Ross, R. S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.004 · Cited by 68
Al‐Fakhri, N., Wilhelm, J., Hahn, M., Heidt, M. C., Hehrlein, F. W., Endisch, A. M., Hupp, T., Cherian, S. M., Bobryshev, Y. V., Lord, R. S. A., et al. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10550 · Cited by 67
METH-2 silencing and promoter hypermethylation in NSCLC
Dunn, J. R., Panutsopulos, D., Shaw, M. W., Heighway, J., Dormer, R., Salmo, E., Watson, S. G., Field, J. K., & Liloglou, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602107 · Cited by 65
Cerretti, D. P., DuBose, R. F., Black, R. A., & Nelson, N. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1322 · Cited by 64
Murphy, G., Knäuper, V., Lee, M., Amour, A., Worley, J. R., Hutton, M., Atkinson, S. J., Rapti, M., & Williamson, R. A. (2003) · Biochemical Society Symposia · doi:10.1042/bss0700065 · Cited by 63
Yavari, R., Adida, C., Bray‐Ward, P., Brines, M. L., & Xu, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1161 · Cited by 63
Pabic, H. L., L’Helgoualc’h, A., Coutant, A., Wewer, U. M., Baffet, G., Clément, B., & Théret, N. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.025 · Cited by 61
East, C. J., Stanton, H., Golub, S. B., Rogerson, F. M., & Fosang, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605750200 · Cited by 61
Statistical modeling and projections of lung cancer mortality in 4 industrialized countries
Shibuya, K., Inoue, M., & López, A. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21078 · Cited by 60
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H.-G., & Reuning, U. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.08.005 · Cited by 59
Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing
Katagiri, T., Harada, Y., Emi, M., & Nakamura, Y. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133884 · Cited by 57
Shigemura, K., Sung, S., Kubo, H., Arnold, R. S., Fujisawa, M., Gotoh, A., Zhau, H. E., & Chung, L. W. K. (2007) · The Prostate · doi:10.1002/pros.20565 · Cited by 56
D’Abaco, G. M., Ng, K., Paradiso, L., Gödde, N., Kaye, A. H., & Novak, U. (2005) · Neurosurgery · doi:10.1227/01.neu.0000192363.84287.8b · Cited by 51
Expression of ADAM15 in lung carcinomas
Schütz, A., Härtig, W., Wobus, M., Grosche, J., Wittekind, C., & Aust, G. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1193-z · Cited by 49
Role of Meltrin α (ADAM12) in Obesity Induced by High- Fat Diet
Masaki, M., Kurisaki, T., Shirakawa, K., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1082 · Cited by 48
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis
Fritzsche, F. R., Jung, M., Xu, C., Rabien, A., Schicktanz, H., Stephan, C., Dietel, M., Jung, K., & Kristiansen, G. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0315-1 · Cited by 45
Joh, T., Kataoka, H., Tanida, S., Watanabe, K., Ohshima, T., Sasaki, M., Nakao, H., Ohhara, H., Higashiyama, S., & Itoh, M. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3011-0 · Cited by 40
Böhm, M., Gerlach, R., Beecken, W.-D. C., Scheuer, T., Stier-Brück, I., & Scharrer, I. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.08.018 · Cited by 31
Harada, T., Nishie, A., Torigoe, K., Ikezaki, K., Shono, T., Maehara, Y., Kuwano, M., & Wada, M. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00877.x · Cited by 21
Bevitt, D. J., Li, Z., Lindrop, J. L., Barker, M. D., Clarke, M. W., & McKie, N. (2005) · Gene · doi:10.1016/j.gene.2005.06.011 · Cited by 21
Kurisaki, T., Wakatsuki, S., & Sehara‐Fujisawa, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03732-8 · Cited by 20
Hormone treatment for prostate cancer: current issues and future directions
Ichikawa, T., Suzuki, H., Ueda, T., Komiya, A., Imamoto, T., & Kojima, S. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0100-x · Cited by 18
Cited by
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Brew, K., & Nagase, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.003 · Cited by 1,381
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
EDWARDS, D., HANDSLEY, M., & PENNINGTON, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,161
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
Mucha, A., Kafarski, P., & Berlicki, Ł. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200587f · Cited by 672
Metadata
- Authors
- Rocks, N., Paulissen, G., El Hour, M., Quesada, F., Crahay, C., Gueders, M., Foidart, J. M., Noel, A., & Cataldo, D.
- Venue
- Biochimie
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 90
- Issue
- 2
- Pages
- 369-379
- ISSN
- 0037-9042 (ISSN-L)
- 0300-9084
- OpenAlex
- W1994859763
- Cited by
- 266
- References
- 146
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.